Liu et al. [16] showed that the selective Cox-2 inhibitor NS 398 did not directly effect tumor cell proliferation of PC-3 prostate carcinomas but suppressed tumor growth through a down regulation of VEGF mediated tumor angiogenesis. This evidence concerns the gene VEGFA and prostate carcinoma.